Personal profile
Research interests
Non-Hodgkin's and Hodgkin's lymphoma, chronic lymphocytic leukemia, hematologic malignancies
Clinical interests
Non-Hodgkin's and Hodgkin's lymphoma, chronic lymphocytic leukemia, hematologic malignancies
Fingerprint
Dive into the research topics where Nancy Bartlett is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up (Blood Cancer Journal, (2025), 15, 1, (129), 10.1038/s41408-025-01329-2)
Domingo-Domènech, E., Pro, B., Illidge, T., Horwitz, S., Trumper, L., Iyer, S., Advani, R., Bartlett, N. L., Christensen, J. H., Kim, W. S., Feldman, T., Choi, I., Gritti, G., Belada, D., Shustov, A., Illes, A., Zinzani, P. L., Hüttmann, A., Trneny, M. & Le Gouill, S. & 7 others, , Dec 2026, In: Blood cancer journal. 16, 1, 21.Research output: Contribution to journal › Comment/debate
Open Access -
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors
Gomez, F., Shea, L., Sharavanan, S. A., Russler-Germain, D., Mosior, M., Krysiak, K., Matlock, M., Skidmore, Z. L., Lee, Y.-S., Duncavage, E. J., O'Laughlin, M., Fronick, C., Fulton, R., Bartlett, N. L., Cashen, A. F., Griffith, M., Fehniger, T. A., Griffith, O. & Wartman, L. D., Jun 2026, In: Cancer Genetics. 304-305, p. 12-20 9 p.Research output: Contribution to journal › Article › peer-review
-
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen
Cochran, H. C. & Bartlett, N. L., Apr 2026, In: Hematology/Oncology Clinics of North America. 40, 2, p. 199-211 13 p.Research output: Contribution to journal › Review article › peer-review
-
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas
Foley, N., Riedell, P. A., Bartlett, N. L., Cashen, A. F., Kahl, B. S., Fehniger, T. A., Fischer, A., Moreno, C., Liu, J., Carson, K. & Mehta-Shah, N., May 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 5, p. 328-336 9 p.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Scopus citations -
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma
Iyer, S., Mehta-Shah, N., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Alpdogan, O., Feldman, T. A., Camus, V., Gritti, G., Zinzani, P. L., Belada, D., Mayer, J., Choi, I., Cheong, J. W., Rustia, E. & Fenton, K. & 3 others, , Dec 9 2025, In: Blood Advances. 9, 23, p. 5976-5987 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations